MetLife Investment Management LLC Takes $103,000 Position in Contineum Therapeutics, Inc. (NASDAQ:CTNM)
MetLife Investment Management LLC acquired a new position in Contineum Therapeutics, Inc. (NASDAQ:CTNM – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 7,029 shares of the company’s stock, valued at approximately $103,000. Other institutional investors have also added to or reduced their […]
